Results 81 to 90 of about 7,611 (182)

Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial. [PDF]

, 2016
OBJECTIVES The aim of this study was to investigate whether the 2 tirofiban formulations tested in the early and late phases of the PRISM (Platelet Receptor Inhibitor in Ischemic Syndrome Management) trial might differ with respect to risk for ...
Windecker, Stephan, Curello, Salvatore, White, Harvey D, Costa, F (Frederico), de Vries, Ton, de Vries, T (Ton), Costa, Francesco, Adamo, Marianna, Moschovitis, A, Moschovitis, Aris, White, HD, Windecker, S, Ariotti, Sara, Valgimigli, Marco, Curello, S   +14 more
core   +1 more source

Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischaemic stroke (ATTRACTION): protocol of a multicentre, prospective, double-blinded, randomised trial

Stroke and Vascular Neurology
Background Successful recanalisation without functional independence is a frequent phenomenon following endovascular thrombectomy (EVT) for large vessel occlusion (LVO) stroke.Aim To demonstrate the safety and efficacy of adjunct tirofiban therapy after ...
Zhouping Tang, Guo Li, Yiming Luo, Gang Deng, Chen-Chen Liu, Sha-Bei Xu, Yi Xie, Qianqian Kong, Yi-Hui Wang, Dong-Hui Ao, Lingning Lan   +10 more
doaj   +1 more source

The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume

Scientific Reports
This study aimed to evaluate the safety and efficacy of intra-arterial (IA) administration of low- dose tirofiban during endovascular therapy in patients with large ischemic core volumes on initial brain CT. Patients were divided into two groups based on
Kwang-Chun Cho, Nak-Hoon Son, So Hyeon Gwon, Jin Wook Choi, Woo Sang Jung   +4 more
doaj   +1 more source

Tirofiban-Induced Thrombocytopenia Occurring with Crohn’s Disease

, 2016
A 69-year-old man, with severe refractory Crohn’s disease, presented with acute coronary syndrome that required angioplasty. He developed severe tirofiban-induced thrombocytopenia (TIT) heralded by type I allergic reaction that required steroids and a ...
Fady El Karak, Toni Ibrahim, Assem Araji, Elie El Rassy   +3 more
core   +1 more source

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting [PDF]

, 2001
OBJECTIVESWe sought to investigate whether abciximab, tirofiban and eptifibatide achieve comparable antiplatelet effects with coronary stenting.BACKGROUNDThe glycoprotein (GP) IIb/IIIa antagonists abciximab, tirofiban and eptifibatide differ in chemical ...
Pogatsa-Murray, Gisela, Albert Schömig, Schömig, Albert, Gisela Pogatsa-Murray, Meinrad Gawaz, Hochholzer, Willibald, Franz-Josef Neumann, Willibald Hochholzer, Neumann, Franz-Josef, Gawaz, Meinrad   +9 more
core   +1 more source

Data_Sheet_1_The impact of intraarterial, intravenous, and combined tirofiban on endovascular treatment for acute intracranial atherosclerotic occlusion.docx

Background and purposeAdjunctive tirofiban administration in patients undergoing endovascular treatment (EVT) for acute large vessel occlusion (LVO) has been investigated in several studies. However, the findings are conflict. This study aimed to compare
Xiaoqing Li (186909), Zhiping Bu (17953769), Zhongrong Miao (562624), Xiaochuan Huo (2141878), Dapeng Mo (619835), Bo Wang (86769), Gaoting Ma (6405032), Gang Luo (425896), Xu Tong (8099873), Feng Gao (3548), Baixue Jia (6376634), Ning Ma (155058), Anxin Wang (101844), Xuan Sun (619836), Ligang Song (619838), Yiming Deng (2814844), Deguo Su (3774229), Dapeng Sun (319496)   +17 more
core   +1 more source

Tirofiban-induced acute profound thrombocytopenia in endovascular therapy for acute ischemic stroke: a rare case report

BMC Neurology
Background Studies have shown that tirofiban (a glycoprotein IIb/IIIa receptor antagonist) is effective in the endovascular treatment of cerebrovascular diseases. However, it has also been reported that tirofiban can cause thrombocytopenia.
Jiuling Liu, Melysze Deanne Oorloff, Adithya Nadella, Yun Yan, Ning Zhou   +4 more
doaj   +1 more source

Effects of Tirofiban on Random Skin Flap Survival in Rats

, 2017
Background Tirofiban is a glycoprotein IIb/IIIa receptor antagonist that is widely used clinically. In the present study, we investigated whether tirofiban promotes flap survival in rat random skin flap model.
Tingxiang Chen, Dingsheng Lin, Liang Cheng, Zhijie Li, Zhenghua Feng, Hang Li   +5 more
core   +1 more source

Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.

PLoS ONE
BackgroundThe RESCUE BT2 trial recently showcased the efficacy of tirofiban in treating acute ischemic stroke (AIS) without large or medium-sized vessel occlusion.
Li Wang, Yuhong Zeng, Limei Zhou, Ping Xu, Xianbin Guo, Yu Xie, Junxiu Cai, Min Pan, Jie Tang, Qingtao Gong, Rong Su, Yan Liu, Yake Lou   +12 more
doaj   +1 more source

Effect of intravenous tirofiban on the radiologic classification of intracranial hemorrhage after endovascular treatment in acute anterior circulation occlusive stroke: results from the RESCUE BT trial

Journal of Stroke and Cerebrovascular Diseases
Purposes: Intracranial hemorrhage (ICH) is a serious complication after endovascular treatment (EVT) for large vessel occlusive stroke. Using data from RESCUE BT, we aimed to investigate the relationship between intravenous tirofiban preceding EVT and ...
Feng Peng, MD, Chunzhen Zhang, MD, Shuiwen Li, MD, Wenjie Zi, PhD, Changwei Guo, PhD, Zhouzhou Peng, PhD, Yun Xiao, MD, Shitao Fan, PhD, Fengli Li, PhD   +8 more
doaj   +1 more source